NOMINEE AND INDEMNITY AGREEMENTNominee and Indemnity Agreement • August 13th, 2021 • BIOS Fund II, LP • Biological products, (no disgnostic substances)
This Nominee And Indemnity Agreement is entered into as of August 13, 2021, by and between BP Directors, LP (“Organization”) and Travis Whitfill (“Holder”).
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • August 13th, 2021 • BIOS Fund II, LP • Biological products, (no disgnostic substances)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
LOCK-UP LETTER AGREEMENTLock-Up Letter Agreement • August 13th, 2021 • BIOS Fund II, LP • Biological products, (no disgnostic substances) • New York
JOINT FILING AGREEMENTJoint Filing Agreement • December 15th, 2023 • BIOS Fund II, LP • Biological products, (no disgnostic substances)
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
